PGP 9.5 expression in cutaneous keratoacanthomas and squamous cell carcinomas

Archives of Dermatological Research

Volumn 301, Issue 9, 2009, Pages 653-658

  Mastoraki, Aikaterini ^a   Ioannidis, Eleftherios ^a   Patsouris, Efstratios ^b   Safioleas, Michael ^a   Aroni, Kiriaki ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Immunohistochemistry; Keratoacanthomas; PGP 9.5; Squamous cell carcinomas

Indexed keywords

GENE PRODUCT; PROTEIN GENE PRODUCT 9.5; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISEASE ACTIVITY; EPIDERMIS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; HUMANS; KERATOACANTHOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN THIOLESTERASE;

EID: 69549116607     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0962-6     Document Type: Article

References (35)

1. NU Ahmed M Ueda M Ichihashi 1997 Increased level of c-erb-2/neu/HER-2 protein in cutaneous squamous cell carcinoma Br J Dermatol 136 908 912 10.1111/j.1365-2133.1997.tb03932.x
2. K Aroni A Mastoraki E Kyriazi, et al. 2007 Silver stained organizer regions and immunoglobulins in cutaneous keratoacanthomas and squamous cell carcinomas Pathol Res Pract 203 659 665 10.1016/j.prp.2007.05.015 (Pubitemid 47300112)
3. PH Asch P Basset M Roos, et al. 1999 Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma Am J Dermatopathol 21 146 150 10.1097/00000372-199904000-00006 (Pubitemid 29162873)
4. A Basta-Juzbasic S Klenkar J Jakic-Razumovic, et al. 2004 Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma Acta Dermatovenerol Croat 12 251 256
5. M Binder A Steiner U Mossbacher, et al. 1998 Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma Am J Dermatopathol 20 453 458 10.1097/00000372-199810000-00004 (Pubitemid 28463410)
6. F Brichory D Beer F LeNaour, et al. 2001 Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer Cancer Res 61 7908 7912
7. R Bustamante D Schmitt GC Pillet, et al. 1977 Immunoglobulin-producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ J Invest Dermatol 68 346 349 10.1111/1523-1747.ep12496474
8. A Ciechanover 1998 The ubiquitin-proteasome pathway: on protein death and cell life EMBO J 17 7151 7160 10.1093/emboj/17.24.7151 (Pubitemid 29002684)
9. JA Diehl F Zindy CJ Sherr CJ, et al. 1997 Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway Genes Dev 11 957 972 10.1101/gad.11.8.957
10. A Fernandez-Flores 2007 Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma Histopathology 50 284 285 10.1111/j.1365-2559.2007.02582.x (Pubitemid 46046400)
11. A Gassenmaier H Pfister OP Hornstein 1986 Human papillomavirus 25-related DNA in solitary keratoacanthoma Arch Dermatol Res 279 73 76 10.1007/BF00417525 (Pubitemid 17042692)
12. H Hackel G Burg W Lechner, et al. 1989 Keratoacanthoma centrifugum marginatum Hautarzt 40 763 766
13. K Hibi Q Liu GA Beaudry, et al. 1998 Serial analysis of gene expression in non-small-cell lung cancer Cancer Res 58 5690 5694
14. K Hibi WH Westra M Borges 1999 PGP 9.5 as a candidate tumor marker for non-small-cell lung cancer Am J Pathol 155 711 715
15. T Ho T Horn E Finzi, et al. 1991 Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas Arch Dermatol 127 1167 1171 10.1001/archderm.127.8.1167
16. M Hochstrasser 1996 Ubiquitin-dependent protein degradation Annu Rev Genet 30 405 439 10.1146/annurev.genet.30.1.405 (Pubitemid 27014474)
17. AL Krunic DR Garrod S Madani, et al. 1998 Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin Br J Cancer 77 1275 1279
18. Lever WF, Schaumburg-Lever G (1991) Tumors and cysts of the epidermis. In: Lever WF, Schaumburg-Lever G (eds) Histopathology of the skin. Lippincott, Philadelphia, pp 560-563
19. ND Melendez M Smoller BR M Morgan 2003 VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas Mod Pathol 16 8 13 10.1097/01.MP.0000043520.74056.CD (Pubitemid 36152680)
20. A Patel GM Halliday BE Cooke, et al. 1994 Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma Br J Dermatol 131 789 798 10.1111/j.1365-2133.1994.tb08580.x (Pubitemid 24373956)
21. H Pilch J Weiss C Heubner, et al. 1994 Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression J Cutan Pathol 21 507 513
22. S Poleksic KY Yeung 1978 Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? Cancer 41 12 16 10.1002/1097-0142(197801)41:1<12::AID-CNCR2820410104>3.0.CO;2-7
23. MJ Rothe M Nowak FA Kerdel 1990 The mast cell in the health and disease Am Acad Dermatol 23 615 624 10.1016/0190-9622(90)70264-I
24. L Schnur P Bozzo 1978 Metastasizing keratoacanthoma. The difficulties in differentiating keratoacanthomas from squamous cell carcinomas Plast Reconstr Surg 62 258 262 10.1097/00006534-197808000-00016
25. JN Schofield IN Day RJ Thompson, et al. 1995 PGP 9.5, a ubiquitin C-terminal hydrolase; pattern of mRNA, and protein expression during neural development in the mouse Brain Res Dev Brain Res 85 229 238 10.1016/0165- 3806(94)00217-N
26. M Slater JA Barden 2005 Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers Histopathology 47 170 178 10.1111/j.1365-2559.2005.02155.x (Pubitemid 41113120)
27. V Spataro C Norbury AL Harris 1998 The ubiquitin-proteasome pathway in cancer Br J Cancer 77 448 455
28. Straka BF, Grant-Kels JM (1991) Keratoacanthoma. In: Friedman RJ (ed) Cancer of the skin. Lippincott, Philadelphia, pp 390-407
29. T Takase K Hibi T Yamazaki, et al. 2003 PGP 9.5 overexpression in esophageal squamous cell carcinoma Hepatogastroenterology 50 1278 1280
30. E Tezel K Hibi T Nagasaka, et al. 2000 PGP9.5 as a prognostic factor in pancreatic cancer Clin Cancer Res 6 4764 4767
31. TA Tran JS Ross JR Boehm, et al. 1999 Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma J Cutan Pathol 26 391 397 10.1111/j.1600-0560.1999.tb01863.x (Pubitemid 29486322)
32. J Viac R Bustamante J Thivolet 1977 Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumor Br J Dermatol 97 1 10 10.1111/j.1365-2133.1977.tb15421.x
33. KD Wilkinson KM Lee SP Deshpande, et al. 1989 The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase Science 246 670 673 10.1126/science.2530630
34. T Wrone-Smith J Bergstrom ME Quevedo, et al. 1999 Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions J Dermatol Sci 19 53 67 10.1016/S0923-1811(98)00052- 8 (Pubitemid 28552872)
35. T Yamazaki K Hibi T Takase, et al. 2002 PGP 9.5 as a marker for invasive colorectal cancer Clin Cancer Res 8 192 195